From the Department of Microbiology and Immunology and Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne 3000, Australia.
Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute and.
J Biol Chem. 2017 Dec 22;292(51):21149-21158. doi: 10.1074/jbc.M117.807719. Epub 2017 Sep 25.
αβ T cell receptors (TCRs) interact with peptides bound to the polymorphic major histocompatibility complex class Ia (MHC-Ia) and class II (MHC-II) molecules as well as the essentially monomorphic MHC class Ib (MHC-Ib) molecules. Although there is a large amount of information on how TCRs engage with MHC-Ia and MHC-II, our understanding of TCR/MHC-Ib interactions is very limited. Infection with cytomegalovirus (CMV) can elicit a CD8 T cell response restricted by the human MHC-Ib molecule human leukocyte antigen (HLA)-E and specific for an epitope from UL40 (VMAPRTLIL), which is characterized by biased TRBV14 gene usage. Here we describe an HLA-E-restricted CD8 T cell able to recognize an allotypic variant of the UL40 peptide with a modification at position 8 (P8) of the peptide (VMAPRTLVL) that uses the TRBV9 gene segment. We report the structures of a TRBV9 TCR in complex with the HLA-E molecule presenting the two peptides. Our data revealed that the TRBV9 TCR adopts a different docking mode and molecular footprint atop HLA-E when compared with the TRBV14 TCR-HLA-E ternary complex. Additionally, despite their differing V gene segment usage and different docking mechanisms, mutational analyses showed that the TCRs shared a conserved energetic footprint on the HLA-E molecule, focused around the peptide-binding groove. Hence, we provide new insights into how monomorphic MHC molecules interact with T cells.
αβ T 细胞受体 (TCRs) 与结合在多态性主要组织相容性复合体 I 类 (MHC-I) 和 II 类 (MHC-II) 分子以及基本上单态性 MHC I 类 (MHC-Ib) 分子上的肽相互作用。尽管有大量关于 TCR 如何与 MHC-Ia 和 MHC-II 相互作用的信息,但我们对 TCR/MHC-Ib 相互作用的理解非常有限。巨细胞病毒 (CMV) 的感染可以引发受人类 MHC-Ib 分子人类白细胞抗原 (HLA)-E 限制的 CD8 T 细胞反应,该反应针对 UL40 的一个表位(VMAPRTLIL)具有特异性,其特征是偏向性 TRBV14 基因使用。在这里,我们描述了一种 HLA-E 限制的 CD8 T 细胞,能够识别 UL40 肽的同种异型变体,该变体在肽的第 8 位(P8)有修饰(VMAPRTLVL),使用 TRBV9 基因片段。我们报告了与呈递两种肽的 HLA-E 分子结合的 TRBV9 TCR 的结构。我们的数据表明,与 TRBV14 TCR-HLA-E 三元复合物相比,TRBV9 TCR 采用了不同的对接模式和分子足迹位于 HLA-E 上方。此外,尽管它们具有不同的 V 基因片段使用和不同的对接机制,但突变分析表明,TCR 共享 HLA-E 分子上的保守能量足迹,集中在肽结合槽周围。因此,我们提供了关于单态性 MHC 分子如何与 T 细胞相互作用的新见解。